The 3D-ASCr scale: A revalidation of the core dimensions of the Altered States of Consciousness Rating Scale 5D(11)-ASC for psychedelic research.
Saved in:
| Title: | The 3D-ASCr scale: A revalidation of the core dimensions of the Altered States of Consciousness Rating Scale 5D(11)-ASC for psychedelic research. |
|---|---|
| Authors: | Stocker K; Psychopharmacology Research, Division of Clinical Pharmacology & Toxicology, Department of Clinical Research, University Hospital Basel, University of Basel, Switzerland.; Chair of Cognitive Science, Department of Humanities, Social and Political Sciences, ETH Swiss Federal Institute of Technology Zurich, Switzerland.; Department of Psychology, University of Zurich, Switzerland.; Faculty of Psychology, UniDistance Suisse, Brig, Switzerland., Hartmann M; Faculty of Psychology, UniDistance Suisse, Brig, Switzerland., Schmid Y; Psychopharmacology Research, Division of Clinical Pharmacology & Toxicology, Department of Clinical Research, University Hospital Basel, University of Basel, Switzerland., Vogt SB; Psychopharmacology Research, Division of Clinical Pharmacology & Toxicology, Department of Clinical Research, University Hospital Basel, University of Basel, Switzerland., Becker AM; Psychopharmacology Research, Division of Clinical Pharmacology & Toxicology, Department of Clinical Research, University Hospital Basel, University of Basel, Switzerland., Ley L; Psychopharmacology Research, Division of Clinical Pharmacology & Toxicology, Department of Clinical Research, University Hospital Basel, University of Basel, Switzerland., Straumann I; Psychopharmacology Research, Division of Clinical Pharmacology & Toxicology, Department of Clinical Research, University Hospital Basel, University of Basel, Switzerland., Arikci D; Psychopharmacology Research, Division of Clinical Pharmacology & Toxicology, Department of Clinical Research, University Hospital Basel, University of Basel, Switzerland., Klaiber A; Psychopharmacology Research, Division of Clinical Pharmacology & Toxicology, Department of Clinical Research, University Hospital Basel, University of Basel, Switzerland., Erne L; Psychopharmacology Research, Division of Clinical Pharmacology & Toxicology, Department of Clinical Research, University Hospital Basel, University of Basel, Switzerland., Vizeli P; Psychopharmacology Research, Division of Clinical Pharmacology & Toxicology, Department of Clinical Research, University Hospital Basel, University of Basel, Switzerland., Holze F; Psychopharmacology Research, Division of Clinical Pharmacology & Toxicology, Department of Clinical Research, University Hospital Basel, University of Basel, Switzerland., Liechti ME; Psychopharmacology Research, Division of Clinical Pharmacology & Toxicology, Department of Clinical Research, University Hospital Basel, University of Basel, Switzerland. |
| Source: | Journal of psychopharmacology (Oxford, England) [J Psychopharmacol] 2026 May; Vol. 40 (5), pp. 850-862. Date of Electronic Publication: 2025 Dec 26. |
| Publication Type: | Journal Article; Randomized Controlled Trial |
| Journal Info: | Publisher: Sage Publications Country of Publication: United States NLM ID: 8907828 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1461-7285 (Electronic) Linking ISSN: 02698811 NLM ISO Abbreviation: J Psychopharmacol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41451514 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: The 3D-ASCr scale: A revalidation of the core dimensions of the Altered States of Consciousness Rating Scale 5D(11)-ASC for psychedelic research. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Stocker+K%22">Stocker K</searchLink>; Psychopharmacology Research, Division of Clinical Pharmacology & Toxicology, Department of Clinical Research, University Hospital Basel, University of Basel, Switzerland.; Chair of Cognitive Science, Department of Humanities, Social and Political Sciences, ETH Swiss Federal Institute of Technology Zurich, Switzerland.; Department of Psychology, University of Zurich, Switzerland.; Faculty of Psychology, UniDistance Suisse, Brig, Switzerland.<br /><searchLink fieldCode="AU" term="%22Hartmann+M%22">Hartmann M</searchLink>; Faculty of Psychology, UniDistance Suisse, Brig, Switzerland.<br /><searchLink fieldCode="AU" term="%22Schmid+Y%22">Schmid Y</searchLink>; Psychopharmacology Research, Division of Clinical Pharmacology & Toxicology, Department of Clinical Research, University Hospital Basel, University of Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Vogt+SB%22">Vogt SB</searchLink>; Psychopharmacology Research, Division of Clinical Pharmacology & Toxicology, Department of Clinical Research, University Hospital Basel, University of Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Becker+AM%22">Becker AM</searchLink>; Psychopharmacology Research, Division of Clinical Pharmacology & Toxicology, Department of Clinical Research, University Hospital Basel, University of Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Ley+L%22">Ley L</searchLink>; Psychopharmacology Research, Division of Clinical Pharmacology & Toxicology, Department of Clinical Research, University Hospital Basel, University of Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Straumann+I%22">Straumann I</searchLink>; Psychopharmacology Research, Division of Clinical Pharmacology & Toxicology, Department of Clinical Research, University Hospital Basel, University of Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Arikci+D%22">Arikci D</searchLink>; Psychopharmacology Research, Division of Clinical Pharmacology & Toxicology, Department of Clinical Research, University Hospital Basel, University of Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Klaiber+A%22">Klaiber A</searchLink>; Psychopharmacology Research, Division of Clinical Pharmacology & Toxicology, Department of Clinical Research, University Hospital Basel, University of Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Erne+L%22">Erne L</searchLink>; Psychopharmacology Research, Division of Clinical Pharmacology & Toxicology, Department of Clinical Research, University Hospital Basel, University of Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Vizeli+P%22">Vizeli P</searchLink>; Psychopharmacology Research, Division of Clinical Pharmacology & Toxicology, Department of Clinical Research, University Hospital Basel, University of Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Holze+F%22">Holze F</searchLink>; Psychopharmacology Research, Division of Clinical Pharmacology & Toxicology, Department of Clinical Research, University Hospital Basel, University of Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Liechti+ME%22">Liechti ME</searchLink>; Psychopharmacology Research, Division of Clinical Pharmacology & Toxicology, Department of Clinical Research, University Hospital Basel, University of Basel, Switzerland. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228907828%22">Journal of psychopharmacology (Oxford, England)</searchLink> [J Psychopharmacol] 2026 May; Vol. 40 (5), pp. 850-862. <i>Date of Electronic Publication: </i>2025 Dec 26. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Randomized Controlled Trial – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Sage+Publications%22">Sage Publications </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8907828 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1461-7285 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2202698811%22">02698811 </searchLink><i>NLM ISO Abbreviation: </i>J Psychopharmacol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41451514 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1177/02698811251397328 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 850 Titles: – TitleFull: The 3D-ASCr scale: A revalidation of the core dimensions of the Altered States of Consciousness Rating Scale 5D(11)-ASC for psychedelic research. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Stocker K – PersonEntity: Name: NameFull: Hartmann M – PersonEntity: Name: NameFull: Schmid Y – PersonEntity: Name: NameFull: Vogt SB – PersonEntity: Name: NameFull: Becker AM – PersonEntity: Name: NameFull: Ley L – PersonEntity: Name: NameFull: Straumann I – PersonEntity: Name: NameFull: Arikci D – PersonEntity: Name: NameFull: Klaiber A – PersonEntity: Name: NameFull: Erne L – PersonEntity: Name: NameFull: Vizeli P – PersonEntity: Name: NameFull: Holze F – PersonEntity: Name: NameFull: Liechti ME IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 05 Text: 2026 May Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1461-7285 Numbering: – Type: volume Value: 40 – Type: issue Value: 5 Titles: – TitleFull: Journal of psychopharmacology (Oxford, England) Type: main |
| ResultId | 1 |